-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shisi Pharmaceutical Ranked Among the Top 100 Chinese Chemical Pharmaceutical Enterprises in Terms of Overall Industrial Strength
Category:
发布时间：2020-10-16
On October 13, the 2020 China Chemical Pharmaceutical Industry Annual Summit was successfully held in Nanjing, Jiangsu Province. During the conference, the “2020 List of Outstanding Enterprises and Outstanding Product Brands in China’s Chemical Pharmaceutical Industry” was unveiled, jointly organized and recommended by the China Association for Pharmaceutical Industry, the China Pharmaceutical Commercial Association, the China Over-the-Counter Drugs Association, the China Vaccine Industry Association, and Sinopharm Reed Exhibitions Co., Ltd.
Shijiazhuang Sihua Pharmaceutical Co., Ltd., leveraging its robust corporate strength, has been honored with four prestigious awards: 27th place on the “Top 100 List of Comprehensive Strength among Industrial Enterprises in China’s Chemical Pharmaceutical Industry,” Outstanding Export-Oriented Formulation Enterprise Brand in China’s Chemical Pharmaceutical Industry, Outstanding Enterprise Brand for Promoting the Integration of Informatization and Industrialization in China’s Chemical Pharmaceutical Industry, and Outstanding Product Brand in the categories of Water, Electrolyte and Acid–Base Balance Regulation, Minerals, and Nutritional Supplements.
Shijiazhuang Fourth Pharmaceutical takes R&D innovation as its guiding principle, vigorously develops its core product portfolio, proactively seizes opportunities in supply-side structural reform and the transition from old to new growth drivers, cultivates new growth areas, and continuously strengthens brand building. The company integrates an excellence-based performance management model into every stage of product development, manufacturing, sales, and service, leveraging technological innovation to accelerate corporate growth and enhancing product competitiveness through robust brand-building efforts. As a result, the company has achieved healthy and rapid development.
Meanwhile, Shijiazhuang No.4 Pharmaceutical Co., Ltd. has steadily advanced its internationalization efforts, with a cumulative total of registrations and export sales in 90 countries and regions, covering more than 200 product specifications and varieties. The company firmly holds the leading position among domestic intravenous solution manufacturers in terms of exports, maintaining double-digit growth in export value for eight consecutive years.
During the conference, a launch ceremony was also held for the “2020 Pharmaceutical Industry Blue Book,” compiled by the China Association of Chemical Pharmaceutical Industry. The book was edited-in-chief by Wen Zaixing, with Pan Guangcheng and Qu Jiguang serving as executive editors-in-chief.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code